![](/img/cover-not-exists.png)
Neutralizing antibodies reduce the efficacy of IFN during treatment of multiple sclerosis
Malucchi, S., Sala, A., Gilli, F., Bottero, R., Di Sapio, A., Capobianco, M., Bertolotto, A.Volume:
62
Language:
english
Journal:
Neurology
DOI:
10.1212/01.WNL.0000129265.73259.9E
Date:
June, 2004
File:
PDF, 213 KB
english, 2004